Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP328000.RAgnp5EckogW0RjoFgZlxe_4_cLfcp1w7_MEFxMq8rRGw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP328000.RAgnp5EckogW0RjoFgZlxe_4_cLfcp1w7_MEFxMq8rRGw130_assertion type Assertion NP328000.RAgnp5EckogW0RjoFgZlxe_4_cLfcp1w7_MEFxMq8rRGw130_head.
- NP328000.RAgnp5EckogW0RjoFgZlxe_4_cLfcp1w7_MEFxMq8rRGw130_assertion description "[Importantly, LATS1 signaling was disrupted by 17-AAG in tumor cell lines in vitro and clinical ovarian cancers in vivo as shown by reduced levels of LATS1 and decreased phosphorylation of the LATS substrate YAP, an oncoprotein transcriptional coactivator that regulates genes involved in cell and tissue growth, including the CTGF gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP328000.RAgnp5EckogW0RjoFgZlxe_4_cLfcp1w7_MEFxMq8rRGw130_provenance.
- NP328000.RAgnp5EckogW0RjoFgZlxe_4_cLfcp1w7_MEFxMq8rRGw130_assertion evidence source_evidence_literature NP328000.RAgnp5EckogW0RjoFgZlxe_4_cLfcp1w7_MEFxMq8rRGw130_provenance.
- NP328000.RAgnp5EckogW0RjoFgZlxe_4_cLfcp1w7_MEFxMq8rRGw130_assertion SIO_000772 20841485 NP328000.RAgnp5EckogW0RjoFgZlxe_4_cLfcp1w7_MEFxMq8rRGw130_provenance.
- NP328000.RAgnp5EckogW0RjoFgZlxe_4_cLfcp1w7_MEFxMq8rRGw130_assertion wasDerivedFrom befree-20140225 NP328000.RAgnp5EckogW0RjoFgZlxe_4_cLfcp1w7_MEFxMq8rRGw130_provenance.
- NP328000.RAgnp5EckogW0RjoFgZlxe_4_cLfcp1w7_MEFxMq8rRGw130_assertion wasGeneratedBy ECO_0000203 NP328000.RAgnp5EckogW0RjoFgZlxe_4_cLfcp1w7_MEFxMq8rRGw130_provenance.